Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Drug Pricing: What A Difference A Year Makes

Jan 02 2019

• By Jessica Merrill

2019 2018 Perspectives

Related Content

Pfizer Agrees To Roll Back Prices On 40 Drugs, Yielding To Pressure From Trump

Jul 11 2018

Rebate Reform: Big Changes Are Looming For The US Drug Market

Nov 12 2018

Medicare's Foreign Price Bench-marking Will Only Hurt Bad Negotiators, HHS's Azar Argues

Oct 26 2018

Industry Makes A Drug Price Transparency Push In DTC Ads, But Is It Too Little Too Late?

Oct 15 2018

Retail Drug Spending In US Flat For 2017 Due Mainly To 'Non-Price' Factors

Dec 07 2018

DTC Ad Proposal: Biopharma, Advertisers Marshall Legal Arguments In Opposition

Dec 19 2018

'Immediate' Steps To Lower Drug Prices: The HHS Action Plan

May 14 2018

The Inevitable Is Coming: Price Increases, Starting With Pfizer

Nov 19 2018

Related Companies

AstraZeneca PLC

Allergan plc

Biogen, Inc.

Bristol Myers Squibb Company

Express Scripts Holding Company

Additional Topics

Pricing Debate Pricing Strategies Policy Business Strategies Commercial BioPharmaceutical

More from Drug Pricing

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window